Andrew Chang, PhD
Cofounder and CEO/ DeepSeq.AI
Andrew Chang is the co-founder and CEO of DeepSeq.AI, a startup providing a data and AI-powered platform for innovative protein design. This platform empowers scientists to create proteins for a wide range of applications, from diagnostics to drug development, with enhanced accuracy, efficiency, and creativity. With a rich background as an AI scientist specializing in DNA and protein engineering, Andrew has not only won several global machine learning competitions but also possesses a profound understanding of the essential factors in building and training versatile AI systems. Before founding DeepSeq.AI, he was instrumental in assisting Bay Area startups in developing both their wet-lab and dry-lab machine learning capabilities. Andrew's postdoctoral work at Genentech was pioneering in using high-throughput DNA sequencing for protein engineering. He holds a Ph.D. in biophysics from the University of Michigan and a BS in physics from National Taiwan University.